JPMorgan Adjusts Stake in Adherium Ltd.
FIL Limited Modifies Stake in Adherium Ltd.
Stocks of the Hour: Adherium, Nanoveu, Nimy Resources
Adherium (ASX:ADR), a leader in respiratory eHealth, remote monitoring and data management solutions, today announced that AstraZeneca has selected its Hailie Smartinhaler platform for a clinical trial.
Adherium Raises Nearly AU$7 Million From Entitlement Offer
Digital health company Adherium (ASX:ADR) raised AU$6.8 million from an entitlement offer of up to 340 million shares at AU$0.02 apiece, according to a Thursday filing with the Australian bourse. The
Bank of America Ends Major Stake in Adherium Ltd
Bank of America Acquires Stake in Adherium Ltd
Adherium Ltd. Sees Major Shareholding Shift
Adherium Seeks to Raise AU$8.4 Million Via Placement, Entitlement Offer; Shares Fall 24%
Adherium (ASX:ADR) is seeking to raise about AU$8.4 million for research and product development; sales, marketing and business development; overseas expansion and staffing; customer onboarding and sc
Adherium Ltd.'s Strategic Capital Raise
Adherium Ltd Requests ASX Trading Halt
Adherium Signs Partnership Deal With Rimidi for Asthma Medication
Adherium (ASX:ADR) signed a partnership deal with Rimidi to integrate its asthma medication solution into the latter's clinical management platform, according to a Wednesday filing with the Australian
Adherium's Research Collaboration With US Intermountain, CareCentra Enrolls First Patient
Digital health company Adherium (ASX:ADR) said the first patient has been enrolled in a new research partnership between US Intermountain Health and CareCentra aimed at examining the benefit of e-heal
Adherium Secures AU$1.5 Million R&D Tax Rebate for Fiscal Year 2023
Adherium (ASX:ADR) secured a AU$1.5 million rebate from the Australian government's research and development tax incentive scheme, according to a filing with the Australian Securities Exchange on Thur
Adherium Appoints CEO
Digital health company Adherium (ASX:ADR) appointed Paul Mastoridis as chief executive, effective Thursday, following the resignation of Rick Legleiter. Mastoridis has more than 25 years' experience i
Adherium and NuvoAir Medical Forge Partnership for Improved Patient Outcomes
Adherium (ASX:ADR) entered an agreement with NuvoAir Medical, under which NuvoAir will purchase a minimum of 1,000 next-generation Hailie Smartinhaler sensors, the digital health company said Wednesda
Adherium Completes Initial Delivery of Hailie Smart Inhaler Sensors to US Intermountain Health; Shares Jump 6%
Adherium (ASX:ADR) delivered the first purchase order agreement for 1,750 next-generation Hailie Smartinhaler sensors to the US hospital system Intermountain Health, the digital health company said Mo
Adherium Confirms Enrolment of First Patients at SENTA Partners
Adherium (ASX:ADR) confirmed the enrolment of the first patients and the start of remote patient monitoring as part of THR commercial rollout of the Hailie platform. The first patients are being monit
Adherium Launches Next-Generation Respiratory Sensors
Adherium (ASX:ADR) launched its next-generation Hailie sensors with physiological parameters capable of connecting established inhalers for monitoring chronic obstructive pulmonary disease and asthma,
Adherium Secures First Patients With US Physician Group
Adherium (ASX:ADR) secured the first patients as part of its collaboration with allergy and asthma physician group Allergy Partners, the medical device firm said on Monday. The patients were enrolled
Adherium Enters Partnership for Rollout of Patient Monitoring Platform in US
Adherium (ASX:ADR) partnered with SENTA Partners for the rollout of the company's Hailie platform to clinics and patients across the latter's network. SENTA Partners is based in Atlanta, Ga. and is on
No Data